Document Detail


Platelet Antiaggregation Therapy and Subinguinal Endovascular Revascularization.
MedLine Citation:
PMID:  23403329     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
BACKGROUND: Platelet antiaggregation therapy (PAT) is widely acknowledged to be a positive prognostic factor after revascularization, either at the coronary or the peripheral level. This study evaluated the results of infrainguinal endovascular procedures performed for critical ischemia, in accordance with patient compliance to clopidogrel treatment. MATERIALS AND METHODS: This retrospective study included patients who underwent infrainguinal endovascular therapy for critical ischemia between January 2003 and December 2009. For 1 month, patients received the same postoperative PAT protocol: aspirin associated with clopidogrel, and then clopidogrel in the long term. Patient follow-up was set at 3 months, 6 months, 1 year, and then yearly thereafter. Survival rates, primary patency (PP), and limb salvage (LS) were studied in accordance with therapy compliance. Patients were classified into 2 groups: group 1 for compliant patients and group 2 for noncompliant patients in the long term. From January 2003 to December 2009, 153 infrainguinal endovascular procedures were performed on 150 patients experiencing critical ischemia who had benefited from the authors' postoperative PAT protocol. RESULTS: Both groups were comparable in terms of comorbidity. Of the procedures performed in groups 1 (N = 105) and 2 (N = 45), 62.8% (n = 66) and 44.4% (n = 20), respectively, were femoral, 14.3% (n = 15) and 22.2% (n = 10), respectively, were infrapopliteal, and 22.9% (n = 24) and 33.4% (n = 15), respectively, were mixed. Mean follow-up time was 30.3 ± 20.2 months (range, 1-70 months). The survival rate was comparable between the groups (P = 0.46). PP and LS rates were significantly higher in group 1 than in group 2 (PP: 84% vs. 80%, respectively, at 1 year, 79% vs. 50%, respectively, at 2 years, 65% vs. 30%, respectively, at 3 years, and 60% vs. 18%, respectively, at 4 years; P = 0.02; LS: 92% vs. 78%, respectively, at 1 year, 86% vs. 62%, respectively, at 2 years, 80% vs. 55%, respectively, at 3 years, and 77% vs. 36%, respectively, at 4 years; P = 0.04). CONCLUSIONS: This study shows that in common practice, 31% of patients stop their clopidogrel therapy, with a negative impact on PP and LS. These results indicate that medical follow-up after endovascular surgery must be reinforced.
Authors:
Anne Lejay; Fabien Thaveau; Boris Aleil; Bernard Geny; Jean-Georges Kretz; Dominique Stephan; Nabil Chakfe
Related Documents :
25315469 - Comparison of effects of spreader grafts and flaring sutures on nasal airway resistance...
17386359 - Pharmacotherapy before and after revascularization: anticoagulation, antiplatelet agent...
23426079 - High platelet reactivity - the challenge of prolonged anticoagulation therapy after acs.
22922489 - Evaluation of long-term outcomes, cytogenetic and molecular responses with imatinib mes...
7458449 - Secondary femoropopliteal reconstruction.
12423299 - The connective tissue graft: a comparative clinical evaluation of wound healing at the ...
18003989 - Radiologically placed venous ports in children.
23574579 - Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of...
6532539 - Prevention and management of urinary tract infections following endoscopic and urologic...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-2-9
Journal Detail:
Title:  Annals of vascular surgery     Volume:  -     ISSN:  1615-5947     ISO Abbreviation:  Ann Vasc Surg     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-2-13     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8703941     Medline TA:  Ann Vasc Surg     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2013 Annals of Vascular Surgery Inc. Published by Elsevier Inc. All rights reserved.
Affiliation:
Service de Chirurgie Vasculaire, Nouvel Hôpital Civil, Strasbourg, France. Electronic address: anne.lejay@chru-strasbourg.fr.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Time Is Brain? - Surgical Revascularization of Acute Symptomatic Occlusion of the Internal Carotid A...
Next Document:  Endovascular Repair With Fenestrated-Branched Stent Grafts Improves 30-Day Outcomes for Complex Aort...